بحث بيانات أعضاء هيئة التدريس
facebook
youtube
googleplus
twitter
zagazig
En
الموقع الشخصى
جلال يحيى عبدالرحيم متولى
الكلية الصيدلة - القسم الميكروبيولوجى والمناعة
الدرجات العلمية
بكالوريوس فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [2006]
دكتوراه فى الميكروبيولوجي والمناعه, -جامعة برشلونة [2016]
التدرج الوظيفى الأكاديمى
معيد : 2/10/2006
مدرس : 31/5/2016
أستاذ مساعد : 28/12/2021
الأبحاث العلمية
1 -
Inntags: small self-structured epitopes for innocuous protein tagging. (1436).
2 -
A Whi7-anchored loop controls the G1 Cdk-cyclin complex at start. (1435).
3 -
Cdc48/p97 segregase is modulated by cyclin‐dependent kinase to determine cyclin fate during G1 progression (1439).
4 -
Competition in the chaperone-client network subordinates cell-cycle entry to growth and stress (1440).
5 -
Phospho-regulation of the Shugoshin - Condensin interaction at the centromere in budding yeast (1441).
6 -
Modulation of cell cycle progression and chromatin dynamic as tolerance mechanisms to salinity and drought stress in maize (1442).
7 -
Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic? (1442).
8 -
In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease (1443).
9 -
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview (1443).
10 -
Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats (1443).
11 -
Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics (1443).
12 -
In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs (1443).
13 -
Stress granules display bistable dynamics modulated by Cdk (1442).
14 -
Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeast (1443).
15 -
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis (1442).
16 -
Soil-Associated Bacillus Species: A Reservoir of Bioactive Compounds with Potential Therapeutic Activity against Human Pathogens (1442).
17 -
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition (1442).
18 -
In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes (1442).
19 -
Peroxiredoxins couple metabolism and cell division in an ultradian cycle (1442).
20 -
The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates (1442).
21 -
The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates (1442).
22 -
GC-MS Analysis and Microbiological Evaluation of Caraway Essential Oil as a Virulence Attenuating Agent against Pseudomonas aeruginosa (1444).
23 -
Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies (1444).
24 -
Combination of Meropenem and Zinc Oxide Nanoparticles; Antimicrobial Synergism, Exaggerated Antibiofilm Activity, and Efficient Therapeutic Strategy against Bacterial Keratitis (1444).
25 -
In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates (1444).
26 -
Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats (1444).
27 -
Blocking prostanoid receptors switches on multiple immune responses and cascades of inflammatory signaling against larval stages in snail fever (1443).
28 -
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need (1443).
29 -
The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury (1443).
30 -
In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease (1443).
31 -
Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats (1443).
32 -
In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs (1443).
33 -
Sublinear scaling of the cellular proteome with ploidy (1444).
34 -
Emerging Approach for the Application of Hibiscus sabdariffa Extract Ointment in the Superficial Burn Care (1443).
35 -
In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates (1444).
36 -
Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies (1444).
37 -
Optimizing Eco-Friendly Degradation of Polyvinyl Chloride (PVC) Plastic Using Environmental Strains of Malassezia Species and Aspergillus fumigatus (1445).
38 -
Genome Analysis of Pseudomonas aeruginosa Strains from Chronically Infected Patients with High Levels of Persister Formation (1444).
39 -
Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae (1445).
40 -
Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi (1445).
41 -
Zingiber officinale rhizome extracts mediated ni nanoparticles and its promising biomedical and environmental applications (1445).
42 -
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 (1445).
43 -
Multifunctional Spirogyra-hyalina-Mediated Barium Oxide Nanoparticles (BaONPs): Synthesis and Applications (1445).
44 -
Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities (1445).
45 -
Antibacterial and Antibiofilm Activity of Ficus carica-Mediated Calcium Oxide (CaONPs) Phyto-Nanoparticles (1445).
46 -
Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials (1444).
47 -
Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring (1444).
48 -
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics (1444).
49 -
Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control (1444).
50 -
Identification of Natural Lead Compounds against Hemagglutinin-Esterase Surface Glycoprotein in Human Coronaviruses Investigated via MD Simulation, Principal Component Analysis, Cross-Correlation, H-Bond Plot and MMGBSA (1444).
51 -
Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice (1444).
52 -
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling (1444).
53 -
Phytoestrogen β-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses (1444).
54 -
The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine (1444).
55 -
COVID-19 surveillance in wastewater: An epidemiological tool for the monitoring of SARS-CoV-2 (1444).
56 -
Pharmaceutical polymers and P-glycoprotein: Current trends and possible outcomes in drug delivery (1444).
57 -
Genome Analysis of Pseudomonas aeruginosa Strains from Chronically Infected Patients with High Levels of Persister Formation (1444).
58 -
The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)’s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19 (1444).
59 -
Optimizing Eco-Friendly Degradation of Polyvinyl Chloride (PVC) Plastic Using Environmental Strains of Malassezia Species and Aspergillus fumigatus (1445).
60 -
Detection and health risk assessment of toxic heavy metals in chilled and frozen meat collected from Sharkia province in Egypt (1445).
61 -
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
62 -
Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 (1446).
63 -
Transcriptomic balance and optimal growth are determined by cell size (1446).
64 -
Recent Advances in the Development of Metal/Metal Oxide Nanoparticle and Antibiotic Conjugates (MNP–Antibiotics) to Address Antibiotic Resistance: Review and Perspective (1446).
65 -
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 (1446).
66 -
Unlocking the therapeutic potential of Nigella sativa extract: phytochemical analysis and revealing antimicrobial and antioxidant marvels (1446).
67 -
Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020 (1445).
68 -
Cell cycle machinery in oncology: A comprehensive review of therapeutic targets (1445).
69 -
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments (1446).
70 -
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021 (1446).
71 -
Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors (1445).
72 -
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy (1445).
73 -
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
74 -
Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae (1445).
75 -
Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 (1446).
76 -
Eco-smart biocontrol strategies utilizing potent microbes for sustainable management of phytopathogenic diseases (1446).
77 -
Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats (1446).
78 -
Isolation, partial characterization, therapeutic, and safety evaluation of carbapenem-resistant Acinetobacter baumannii lytic phage in a mouse model (1446).
79 -
The battle against dental caries: defeating biofilm formed by bacterial isolates using vanillin and plant essential oils: in vitro and ex vivo approaches (1446).
80 -
Bacteria-powered self-healing concrete: Breakthroughs, challenges, and future prospects (1446).
81 -
Streptomyces Paradigm in Anticancer Therapy: A State-of-the Art Review (1445).
82 -
Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats (1446).
83 -
Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fght carbapenem-resistant Klebsiella pneumoniae (1445).
84 -
The battle against dental caries: defeating bioflm formed by bacterial isolates using vanillin and plant essential oils: in vitro and ex vivo approaches (1446).
85 -
Chemical profile, virtual screening, and virulence-inhibiting properties of Sphagneticola trilobata L. essential oils against Pseudomonas aeruginosa (1446).
86 -
From Isolation to Application: Utilising Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis (1446).
87 -
Innovative antifungal Therapy: In vivo evaluation of 3-Ethyl-6,7-Dihydroxy-2-Phenyl-Chromen-4-One purified from Alpinia officinarum on Cryptococcus neoformans (1446).
88 -
Chemical profile, virtual screening, and virulence-inhibiting properties of Sphagneticola trilobata L. essential oils against Pseudomonas aeruginosa (1446).
89 -
Revitalizing Pleurotus eryngii polysaccharides: gamma irradiation boosts antidiabetic and antioxidant potential (1446).
90 -
From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications
91 -
Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline
92 -
Cold Plasma as a Revolutionary Antimicrobial Modality: A Multifaceted Weapon Against Antibiotic Resistance (1447).
93 -
Repurposing rupatadine as topical treatment against methicillin-resistant Staphylococcus aureus (1447).
94 -
Computational discovery of BRD4 inhibitors for neuroblastoma therapy using pharmacophore screening and molecular simulations (1447).
95 -
Ligand-based discovery of novel N-arylpyrrole derivatives as broad-spectrum antimicrobial agents with antibiofilm and anti-virulence activity (1447).
96 -
Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy (1447).
97 -
Comprehensive review for aflatoxin detoxification with special attention to cold plasma treatment (1446).
98 -
Silk fibroin/gelatin electrospun nanofibrous dressing loaded with roxadustat accelerates wound healing in diabetic rats via HIF-1α stabilization (1446).
99 -
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
100 -
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 (1446).
101 -
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
102 -
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 202 (1447).
103 -
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
104 -
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
105 -
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
106 -
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
المجالات البحثية
Microbiology, immunology and Molecular biology
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
شراقوة | الشرقية بين ايديك
اخبار الشرقية - شراقوة | الشرقية بين ايديك
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف
